TALAZOPARIB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 18 adverse event reports in the FDA FAERS database where TALAZOPARIB was used for Neoplasm malignant.
Most Reported Side Effects for TALAZOPARIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Anaemia | 219 | 14.8% | 20 | 80 |
| Neoplasm progression | 169 | 11.4% | 54 | 37 |
| Death | 142 | 9.6% | 142 | 9 |
| Off label use | 78 | 5.3% | 16 | 13 |
| Thrombocytopenia | 78 | 5.3% | 17 | 33 |
| Fatigue | 77 | 5.2% | 5 | 17 |
| Platelet count decreased | 68 | 4.6% | 8 | 30 |
| Haemoglobin decreased | 65 | 4.4% | 1 | 24 |
| Febrile neutropenia | 60 | 4.1% | 9 | 52 |
| Pancytopenia | 60 | 4.1% | 7 | 24 |
| Nausea | 53 | 3.6% | 3 | 17 |
| Neutropenia | 47 | 3.2% | 3 | 13 |
| Dyspnoea | 43 | 2.9% | 12 | 29 |
| Asthenia | 39 | 2.6% | 3 | 16 |
| Haematotoxicity | 38 | 2.6% | 1 | 5 |
Other Indications for TALAZOPARIB
Prostate cancer metastatic (155)
Breast cancer metastatic (146)
Prostate cancer (125)
Breast cancer (119)
Breast cancer female (69)
Hormone-refractory prostate cancer (69)
Product used for unknown indication (61)
Neoplasm (29)
Triple negative breast cancer (26)
Ovarian cancer (18)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)